open access

Vol 69, No 3-4 (2019)
Original articles
Published online: 2019-10-31
Get Citation

Treatment of patients with primary cutaneous lymphomas – real-life data

Ewa Chmielowska, Aleksandra Grzanka-Gadzińska, Maciej Studziński, Anna Krause, Monika Olejniczak, Michał Marjański, Karolina Wróblewska, Małgorzata Sokołowska-Wojdyło
DOI: 10.5603/NJO.2019.0016
·
Nowotwory. Journal of Oncology 2019;69(3-4):77-82.

open access

Vol 69, No 3-4 (2019)
Original articles
Published online: 2019-10-31

Abstract

Background. Primary cutaneous lymphomas (PCL) comprise a heterogeneous group of neoplasms of mature lymphocytes with skin tropism. Although, by definition, these lymphomas are restricted to the skin at the time of diagnosis, during the course of the disease it may involve also lymph nodes and visceral organs. A close cooperation between a dermatologist and oncologist is required to ensure proper treatment. We present in a real-life data on treatment of patients with PCL between dermatology and oncology department.

Material and methods. 104 patients were registered in a joined database of Oncology Department of Oncology Centre in Bydgoszcz and Dermatology Department of Medical University in Toruń between 2007 and 2017. Due to different clinical and prognostic features data from MF/SS (44 patients), non-MF/SS CTCLs and CBCLs were presented separately.

Results. Median overall survival for patients with MF/SS was 76.7 months. Median follow-up time was 5 years.

Abstract

Background. Primary cutaneous lymphomas (PCL) comprise a heterogeneous group of neoplasms of mature lymphocytes with skin tropism. Although, by definition, these lymphomas are restricted to the skin at the time of diagnosis, during the course of the disease it may involve also lymph nodes and visceral organs. A close cooperation between a dermatologist and oncologist is required to ensure proper treatment. We present in a real-life data on treatment of patients with PCL between dermatology and oncology department.

Material and methods. 104 patients were registered in a joined database of Oncology Department of Oncology Centre in Bydgoszcz and Dermatology Department of Medical University in Toruń between 2007 and 2017. Due to different clinical and prognostic features data from MF/SS (44 patients), non-MF/SS CTCLs and CBCLs were presented separately.

Results. Median overall survival for patients with MF/SS was 76.7 months. Median follow-up time was 5 years.

Get Citation

Keywords

cutaneous lymphoma; follow-up data; mycosis fungoides; daily practice

About this article
Title

Treatment of patients with primary cutaneous lymphomas – real-life data

Journal

Nowotwory. Journal of Oncology

Issue

Vol 69, No 3-4 (2019)

Pages

77-82

Published online

2019-10-31

DOI

10.5603/NJO.2019.0016

Bibliographic record

Nowotwory. Journal of Oncology 2019;69(3-4):77-82.

Keywords

cutaneous lymphoma
follow-up data
mycosis fungoides
daily practice

Authors

Ewa Chmielowska
Aleksandra Grzanka-Gadzińska
Maciej Studziński
Anna Krause
Monika Olejniczak
Michał Marjański
Karolina Wróblewska
Małgorzata Sokołowska-Wojdyło

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl